Twist Bioscience (TWST) Assets Average (2018 - 2026)

Twist Bioscience (TWST) has 9 years of Assets Average data on file, last reported at $657.1 million in Q1 2026.

• Assets Average for Q1 2026 came in at $657.1 million, up 9.14% year-over-year; the trailing twelve-month figure through Mar 2026 was $657.1 million (up 9.14% YoY), and the FY2025 annual result was $628.1 million, down 9.67% from the prior year.
• Assets Average rose to $657.1 million in Q1 2026 per TWST's latest filing, from $640.0 million in the prior quarter.
• Over five years, Assets Average peaked at $1.0 billion in Q2 2022 and troughed at $602.1 million in Q1 2025.
• A 5-year average of $756.5 million and a median of $717.8 million in 2024 frame the typical range for Assets Average.
• The sharpest annual moves came in 2022 and 2024: Assets Average jumped 42.69% in 2022, then slipped 21.07% in 2024.
• A 5-year view of Assets Average shows it stood at $935.7 million in 2022, then declined by 19.35% to $754.6 million in 2023, then dropped by 18.97% to $611.5 million in 2024, then rose by 4.66% to $640.0 million in 2025, then gained by 2.68% to $657.1 million in 2026.
• Business Quant data shows TWST's Assets Average at $657.1 million in Q1 2026, $640.0 million in Q4 2025, and $642.7 million in Q3 2025.